- Home
- GPRK vs TMCI Comparison
GPRK vs TMCI Comparison
Compare GPRK & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- TMCI
- Stock Information
- Founded
- GPRK 2002
- TMCI 2014
- Country
- GPRK Colombia
- TMCI United States
- Employees
- GPRK N/A
- TMCI N/A
- Industry
- GPRK Oil & Gas Production
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GPRK Energy
- TMCI Health Care
- Exchange
- GPRK Nasdaq
- TMCI Nasdaq
- Market Cap
- GPRK 408.5M
- TMCI 329.0M
- IPO Year
- GPRK N/A
- TMCI 2021
- Fundamental
- Price
- GPRK $8.28
- TMCI $7.94
- Analyst Decision
- GPRK Strong Buy
- TMCI Hold
- Analyst Count
- GPRK 2
- TMCI 6
- Target Price
- GPRK $12.50
- TMCI $7.40
- AVG Volume (30 Days)
- GPRK 302.7K
- TMCI 794.3K
- Earning Date
- GPRK 11-06-2024
- TMCI 11-05-2024
- Dividend Yield
- GPRK 7.05%
- TMCI N/A
- EPS Growth
- GPRK N/A
- TMCI N/A
- EPS
- GPRK 1.97
- TMCI N/A
- Revenue
- GPRK $716,838,000.00
- TMCI $202,861,000.00
- Revenue This Year
- GPRK N/A
- TMCI $13.15
- Revenue Next Year
- GPRK $3.44
- TMCI $8.36
- P/E Ratio
- GPRK $4.22
- TMCI N/A
- Revenue Growth
- GPRK N/A
- TMCI 16.14
- 52 Week Low
- GPRK $7.24
- TMCI $3.92
- 52 Week High
- GPRK $11.25
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- GPRK 51.57
- TMCI 69.09
- Support Level
- GPRK $7.96
- TMCI $7.21
- Resistance Level
- GPRK $8.86
- TMCI $8.37
- Average True Range (ATR)
- GPRK 0.32
- TMCI 0.49
- MACD
- GPRK 0.03
- TMCI 0.07
- Stochastic Oscillator
- GPRK 43.75
- TMCI 88.40
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil and Argentina. The company generates revenue from the sale of crude oil, condensate and natural gas net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.